Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-29 Sale | 2026-10-01 6:00 pm | Revolution Medicines Inc. | RVMD | Sandler Alan B. Chief Development Officer | 6,309 | $202.14 | $1,275,294 | 213,859 (Direct) | View |
| 2026-09-25 Sale | 2026-09-29 6:00 pm | Revolution Medicines Inc. | RVMD | Cislini Jeff SVP & General Counsel | 765 | $207.32 | $158,600 | 51,776 (Direct) | View |
| 2026-09-24 Sale | 2026-09-28 6:00 pm | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 3,708 | $200.45 | $743,285 | 133,390 (Direct) | View |
| 2026-09-22 Sale | 2026-09-24 6:00 pm | Revolution Medicines Inc. | RVMD | ANDERSON ELIZABETH M Director | 10,143 | $193.04 | $1,958,016 | 47,418 (Indirect Direct) | View |
| 2026-09-18 Sale | 2026-09-22 6:00 pm | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 1,764 | $196.94 | $347,402 | 40,352 (Direct) | View |
| 2026-09-16 Sale | 2026-09-18 6:06 pm | Revolution Medicines Inc. | RVMD | Sandler Alan B. Chief Development Officer | 341 | $199.24 | $67,941 | 52,868 (Direct) | View |
| 2026-09-16 Sale | 2026-09-18 6:05 pm | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 1,774 | $199.24 | $353,449 | 42,116 (Direct) | View |
| 2026-09-16 Sale | 2026-09-18 6:04 pm | Revolution Medicines Inc. | RVMD | Kelsey Stephen Michael See Remarks | 5,569 | $199.24 | $1,109,554 | 286,307 (Direct) | View |
| 2026-09-16 Sale | 2026-09-18 6:03 pm | Revolution Medicines Inc. | RVMD | Horn Margaret A Chief Operating Officer | 4,967 | $199.24 | $989,613 | 149,680 (Direct) | View |
| 2026-09-16 Sale | 2026-09-18 6:02 pm | Revolution Medicines Inc. | RVMD | GOLDSMITH MARK A See Remarks | 13,988 | $199.24 | $2,786,938 | 970,250 (Indirect Direct) | View |
| 2026-09-16 Sale | 2026-09-18 6:01 pm | Revolution Medicines Inc. | RVMD | Cislini Jeff SVP & General Counsel | 3,366 | $199.24 | $670,631 | 52,541 (Direct) | View |
| 2026-09-16 Sale | 2026-09-18 6:00 pm | Revolution Medicines Inc. | RVMD | Anders Jack Chief Financial Officer | 4,053 | $199.24 | $807,513 | 119,216 (Direct) | View |
| 2026-09-11 Sale | 2026-09-15 6:00 pm | Revolution Medicines Inc. | RVMD | Kelsey Stephen Michael See Remarks | 92,531 | $202.36 | $18,724,767 | 379,945 (Direct) | View |
| 2026-09-10 Sale | 2026-09-14 6:03 pm | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 15,448 | $204.16 | $3,153,807 | 140,636 (Direct) | View |
| 2026-09-08 Sale | 2026-09-10 5:52 pm | Revolution Medicines Inc. | RVMD | Kim Lorence H. Director | 17,090 | $209.82 | $3,585,837 | 1,191 (Indirect Direct) | View |
| 2026-08-31 Sale | 2026-09-02 4:30 pm | Revolution Medicines Inc. | RVMD | Kim Lorence H. Director | 56,000 | $203.24 | $11,381,288 | 18,281 (Indirect Direct) | View |
| 2026-08-21 Sale | 2026-08-25 4:06 pm | Revolution Medicines Inc. | RVMD | Cislini Jeff General Counsel | 56,894 | $209.24 | $11,904,247 | 59,407 (Direct) | View |
| 2026-08-21 Sale | 2026-08-25 4:06 pm | Revolution Medicines Inc. | RVMD | GOLDSMITH MARK A See Remarks | 86,000 | $209.2 | $17,991,107 | 1,266,899 (Indirect Direct) | View |
| 2026-06-29 Sale | 2026-07-01 6:25 pm | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 5,580 | $187.99 | $1,048,967 | 34,656 (Direct) | View |
| 2026-06-24 Sale | 2026-06-26 4:10 pm | Revolution Medicines Inc. | RVMD | Anders Jack Chief Financial Officer | 20,000 | $168.33 | $3,366,604 | 143,869 (Direct) | View |
| 2026-06-16 Sale | 2026-06-18 4:11 pm | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 4,615 | $156.12 | $720,490 | 49,975 (Direct) | View |
| 2026-06-16 Sale | 2026-06-18 4:11 pm | Revolution Medicines Inc. | RVMD | GOLDSMITH MARK A See Remarks | 10,020 | $156.12 | $1,564,310 | 990,238 (Indirect Direct) | View |
| 2026-06-16 Sale | 2026-06-18 4:10 pm | Revolution Medicines Inc. | RVMD | Cislini Jeff General Counsel | 2,157 | $156.12 | $336,749 | 56,521 (Direct) | View |
| 2026-06-16 Sale | 2026-06-18 4:10 pm | Revolution Medicines Inc. | RVMD | Anders Jack Chief Financial Officer | 2,722 | $156.12 | $424,956 | 123,269 (Direct) | View |
| 2026-06-16 Sale | 2026-06-18 4:10 pm | Revolution Medicines Inc. | RVMD | Kelsey Stephen Michael See Remarks | 4,175 | $156.12 | $651,798 | 291,876 (Direct) | View |
| 2025-06-16 Sale | 2026-06-17 7:51 pm | Revolution Medicines Inc. | RVMD | Horn Margaret A Chief Operating Officer | 93,575 | $160 | $14,972,110 | 566,447 (Direct) | View |
| 2026-06-11 Sale | 2026-06-15 4:05 pm | Revolution Medicines Inc. | RVMD | Horn Margaret A Chief Operating Officer | 10,000 | $148.01 | $1,480,139 | 249,416 (Direct) | View |
| 2026-05-26 Sale | 2026-05-28 4:10 pm | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 3,121 | $153.99 | $480,611 | 160,509 (Direct) | View |
| 2026-04-27 Sale | 2026-04-29 5:50 pm | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 3,120 | $132.41 | $413,129 | 163,630 (Direct) | View |
| 2026-04-15 Sale | 2026-04-17 7:26 pm | Revolution Medicines Inc. | RVMD | GOLDSMITH MARK A See Remarks | 120,000 | $150.09 | $18,010,488 | 1,448,155 (Indirect Direct) | View |
| 2026-03-25 Sale | 2026-03-26 8:04 pm | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 37,450 | $95.56 | $3,578,821 | 166,750 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-29 Exercise | 2026-10-01 6:00 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Sandler Alan B. Chief Development Officer | 6,000 | $58.84 | 213,859 (Direct) | View |
| 2026-09-29 Exercise | 2026-10-01 6:00 pm | N/A 2035-11-01 | Revolution Medicines Inc. | RVMD | Sandler Alan B. Chief Development Officer | 6,000 | $0 | 213,859 (Direct) | View |
| 2026-09-25 Exercise | 2026-09-28 6:00 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 3,121 | $33.62 | 133,390 (Direct) | View |
| 2026-09-25 Exercise | 2026-09-28 6:00 pm | N/A 2035-03-31 | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 3,121 | $0 | 133,390 (Direct) | View |
| 2026-09-22 Exercise | 2026-09-24 6:00 pm | N/A N/A | Revolution Medicines Inc. | RVMD | ANDERSON ELIZABETH M Director | 5,070 | $1.12 | 47,418 (Direct) | View |
| 2026-09-22 Exercise | 2026-09-24 6:00 pm | N/A 2028-04-19 | Revolution Medicines Inc. | RVMD | ANDERSON ELIZABETH M Director | 5,070 | $0 | 47,418 (Direct) | View |
| 2026-09-11 Exercise | 2026-09-15 6:00 pm | N/A 2031-03-04 | Revolution Medicines Inc. | RVMD | Kelsey Stephen Michael See Remarks | 52,500 | $42.45 | 379,945 (Direct) | View |
| 2026-09-11 Exercise | 2026-09-15 6:00 pm | N/A 2035-03-01 | Revolution Medicines Inc. | RVMD | Kelsey Stephen Michael See Remarks | 40,031 | $40.74 | 379,945 (Direct) | View |
| 2026-09-10 Exercise | 2026-09-14 6:03 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 9,363 | $33.62 | 140,636 (Direct) | View |
| 2026-09-10 Exercise | 2026-09-14 6:03 pm | N/A 2035-03-31 | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 9,363 | $0 | 140,636 (Direct) | View |
| 2026-08-21 Exercise | 2026-08-25 4:06 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Cislini Jeff General Counsel | 29,680 | $18.56 | 59,407 (Direct) | View |
| 2026-08-21 Exercise | 2026-08-25 4:06 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Cislini Jeff General Counsel | 26,600 | $21.61 | 59,407 (Direct) | View |
| 2026-08-21 Exercise | 2026-08-25 4:06 pm | 2026-03-01 2032-02-29 | Revolution Medicines Inc. | RVMD | Cislini Jeff General Counsel | 56,280 | $0 | 59,407 (Direct) | View |
| 2026-08-21 Exercise | 2026-08-25 4:06 pm | N/A N/A | Revolution Medicines Inc. | RVMD | GOLDSMITH MARK A See Remarks | 80,000 | $4.73 | 1,266,899 (Direct) | View |
| 2026-08-21 Exercise | 2026-08-25 4:06 pm | 2023-08-09 2029-08-08 | Revolution Medicines Inc. | RVMD | GOLDSMITH MARK A See Remarks | 80,000 | $0 | 1,266,899 (Direct) | View |
| 2026-06-29 Exercise | 2026-07-01 6:25 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 2,955 | $37.54 | 34,656 (Direct) | View |
| 2026-06-29 Exercise | 2026-07-01 6:25 pm | N/A 2034-06-19 | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 2,955 | $0 | 34,656 (Direct) | View |
| 2026-06-24 Exercise | 2026-06-26 4:10 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Anders Jack Chief Financial Officer | 20,000 | $18.56 | 143,869 (Direct) | View |
| 2026-06-24 Exercise | 2026-06-26 4:10 pm | 2026-03-01 2032-02-29 | Revolution Medicines Inc. | RVMD | Anders Jack Chief Financial Officer | 20,000 | $0 | 143,869 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-23 5:57 pm | N/A 2036-06-18 | Revolution Medicines Inc. | RVMD | Kim Lorence H. Director | 4,318 | $0 | 77,408 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-23 5:52 pm | N/A 2036-06-18 | Revolution Medicines Inc. | RVMD | Borisy Alexis Director | 4,318 | $0 | 2,343,202 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-23 5:45 pm | N/A 2036-06-18 | Revolution Medicines Inc. | RVMD | ANDERSON ELIZABETH M Director | 4,318 | $0 | 39,523 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-23 5:45 pm | N/A 2036-06-18 | Revolution Medicines Inc. | RVMD | Horning Sandra Director | 4,318 | $0 | 100,892 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-23 5:44 pm | N/A 2036-06-18 | Revolution Medicines Inc. | RVMD | Clyburn Frank Director | 4,318 | $0 | 14,056 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-23 5:43 pm | N/A 2036-06-18 | Revolution Medicines Inc. | RVMD | Patel Sushil Director | 4,318 | $0 | 27,408 (Direct) | View |
| 2026-06-18 Option Award | 2026-06-23 5:42 pm | N/A 2036-06-18 | Revolution Medicines Inc. | RVMD | Borellini Flavia Director | 4,318 | $0 | 29,342 (Direct) | View |
| 2026-06-15 Exercise | 2026-06-17 7:51 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Horn Margaret A Chief Operating Officer | 48,156 | $29.8 | 566,447 (Direct) | View |
| 2026-06-15 Exercise | 2026-06-17 7:51 pm | N/A 2035-02-28 | Revolution Medicines Inc. | RVMD | Horn Margaret A Chief Operating Officer | 90,000 | $0 | 566,447 (Direct) | View |
| 2026-06-15 Exercise | 2026-06-17 7:51 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Horn Margaret A Chief Operating Officer | 16,119 | $40.74 | 566,447 (Direct) | View |
| 2026-06-17 Exercise | 2026-06-17 7:51 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Horn Margaret A Chief Operating Officer | 25,725 | $26.5 | 566,447 (Direct) | View |
| 2026-06-11 Exercise | 2026-06-15 4:05 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Horn Margaret A Chief Operating Officer | 1,094 | $42.45 | 249,416 (Direct) | View |
| 2026-06-11 Exercise | 2026-06-15 4:05 pm | 2023-08-09 2031-03-03 | Revolution Medicines Inc. | RVMD | Horn Margaret A Chief Operating Officer | 10,000 | $0 | 249,416 (Direct) | View |
| 2026-06-11 Exercise | 2026-06-15 4:05 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Horn Margaret A Chief Operating Officer | 8,906 | $40.74 | 249,416 (Direct) | View |
| 2026-05-26 Exercise | 2026-05-28 4:10 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 3,121 | $33.62 | 160,509 (Direct) | View |
| 2026-05-26 Exercise | 2026-05-28 4:10 pm | N/A 2035-03-31 | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 3,121 | $0 | 160,509 (Direct) | View |
| 2026-04-27 Exercise | 2026-04-29 5:50 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 3,120 | $33.62 | 163,630 (Direct) | View |
| 2026-04-27 Exercise | 2026-04-29 5:50 pm | N/A 2035-03-31 | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 3,120 | $0 | 163,630 (Direct) | View |
| 2026-04-15 Exercise | 2026-04-17 7:26 pm | N/A N/A | Revolution Medicines Inc. | RVMD | GOLDSMITH MARK A See Remarks | 96,756 | $4.73 | 1,448,155 (Direct) | View |
| 2026-04-15 Exercise | 2026-04-17 7:26 pm | N/A N/A | Revolution Medicines Inc. | RVMD | GOLDSMITH MARK A See Remarks | 23,244 | $4.09 | 1,448,155 (Direct) | View |
| 2026-04-15 Exercise | 2026-04-17 7:26 pm | 2023-03-13 2029-03-12 | Revolution Medicines Inc. | RVMD | GOLDSMITH MARK A See Remarks | 120,000 | $0 | 1,448,155 (Direct) | View |
| 2026-03-25 Exercise | 2026-03-26 8:04 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 37,450 | $33.62 | 166,750 (Direct) | View |
| 2026-03-25 Exercise | 2026-03-26 8:04 pm | N/A 2035-03-31 | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 37,450 | $0 | 166,750 (Direct) | View |
Ownership | 2026-03-26 6:44 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Mancini Anthony See Remarks | 0 | $0 | 230,400 (Direct) | View |
Ownership | 2026-03-26 6:35 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Sandler Alan B. Chief Development Officer | 0 | $0 | 232,000 (Direct) | View |